Buda Alessandro, Di Martino Giampaolo, Restaino Stefano, De Ponti Elena, Monterossi Giorgia, Giuliani Daniela, Ercoli Alfredo, Dell'Orto Federica, Dinoi Giorgia, Grassi Tommaso, Scambia Giovanni, Fanfani Francesco
Gynecologic Oncology Unit, Department of Obstetrics and Gynecology, ASST-Monza, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy.
Gynecologic Oncology Unit, Department of Obstetrics and Gynecology, ASST-Monza, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy.
Gynecol Oncol. 2017 Dec;147(3):528-534. doi: 10.1016/j.ygyno.2017.09.033. Epub 2017 Oct 9.
The role of lymphadenectomy in endometrial cancer is still uncertain. We aimed to evaluate the survival outcomes of two different strategies in apparent uterine confined disease by comparing sentinel lymph node (SLN) mapping and selective lymphadenectomy (LD).
We retrospectively reviewed women with preoperative stage I endometrial cancer underwent surgical staging with either SLN mapping, or LD in two Italian centers.
Eight hundred and two women underwent surgical staging for preoperative stage I endometrial cancer were revised (145 Monza; 657 Rome). All patients underwent peritoneal washing, simple hysterectomy with bilateral salpingo-oophorectomy and nodal staging including SLN mapping, or LD. Overall 8229 lymph nodes were removed (1595 in Monza, 6634 in Rome). Pelvic lymphadenectomy was performed in 33.1% and 52.4% in Monza and Rome, respectively (p<0.001). Patients with positive pelvic LN were 16.7% and 7.3%, in SLN and LD groups, respectively (p=0.002). Disease-free survival (DFS) curves did not showed a statistically significant difference between centers and strategies adopted (SLN mapping, LD, SLN+LD) with a HR of 0.87 (95% CI 0.63-2.16; p=0.475).
Survival outcomes were similar for both strategies. The SLN strategy allowed to identify a higher rate of stage IIIC1 disease even with a lower median number of lymph node removed in SLN group. Applying a SLN algorithm does not impair the prognosis of endometrial cancer patients. The clinical impact and management of low volume metastasis in high-risk patients should be further clarify.
淋巴结切除术在子宫内膜癌中的作用仍不明确。我们旨在通过比较前哨淋巴结(SLN)定位和选择性淋巴结切除术(LD),评估两种不同策略在明显局限于子宫疾病中的生存结局。
我们回顾性分析了在意大利两个中心接受手术分期的术前I期子宫内膜癌女性患者,这些患者接受了SLN定位或LD。
对802例接受术前I期子宫内膜癌手术分期的女性患者进行了分析(145例来自蒙扎;657例来自罗马)。所有患者均接受了腹腔冲洗、单纯子宫切除术加双侧输卵管卵巢切除术以及包括SLN定位或LD的淋巴结分期。共切除8229枚淋巴结(蒙扎1595枚,罗马6634枚)。蒙扎和罗马分别有33.1%和52.4%的患者接受了盆腔淋巴结切除术(p<0.001)。SLN组和LD组盆腔淋巴结阳性患者分别为16.7%和7.3%(p=0.002)。无病生存(DFS)曲线在不同中心和所采用的策略(SLN定位、LD、SLN+LD)之间未显示出统计学显著差异,风险比为0.87(95%CI 0.63 - 2.16;p=0.475)。
两种策略的生存结局相似。SLN策略即使在SLN组切除的淋巴结中位数较低的情况下,也能识别出更高比例的IIIC1期疾病。应用SLN算法不会损害子宫内膜癌患者的预后。高危患者中低容量转移的临床影响和管理应进一步明确。